Celyad Sa Ads (NQ: CYAD )

6.970 USD +0.160 (+2.35%)

Streaming Delayed Price Updated: 9:43 AM EDT, Apr 19, 2021 Add to My Watchlist

Price and Volume

Volume	4,708
Open	6.960
Bid (Size)	6.920 (5)
Ask (Size)	7.010 (6)
Prev. Close	6.810
Today's Range	6.930 - 6.980
52wk Range	6.570 - 13.01
Shares Outstanding	13,942,344
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Celyad Oncology Appoints Dr. Charles Morris as Chief Medical Officer

Today 1:00 EDT

Celyad Oncology Announces April 2021 Conference Schedule

April 01, 2021

Performance

YTD	-14.27%	-14.27%
1 Month	-7.68%	-7.68%
3 Month	-20.34%	-20.34%
6 Month	-17.07%	-17.07%
1 Year	-25.17%	-25.17%

More News

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

March 31, 2021

Celyad Oncology Reports Full Year 2020 Financial Results and Recent Business Highlights

March 24, 2021

Celyad Oncology to Announce Full Year 2020 Financial Results and Host Conference Call

March 18, 2021

Celyad Oncology Announces March 2021 Conference Schedule

March 01, 2021

Celyad Oncology Announces February 2021 Conference Schedule

February 02, 2021

Information on the Total Number of Voting Rights and Shares (Articles 15 of the Law of 2 May 2007)

January 20, 2021

Celyad Oncology Presents Data Update from Phase 1 alloSHRINK Trial for CYAD-101 in mCRC at ASCO-GI Symposium

January 18, 2021

Celyad Oncology Appoints Marina Udier, Ph.D., to Board of Directors

January 11, 2021

Celyad Oncology Announces Equity Purchase Agreement for up to $40 Million with Lincoln Park Capital

January 07, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.